Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eleven Bio faces cash crunch as lead drug flunks another PhIII
Eleven Bio faces cash crunch as lead drug flunks another PhIII
Eleven Bio faces cash crunch as lead drug flunks another PhIII
Submitted by
admin
on January 17, 2016 - 12:12pm
Source:
Fierce Biotech
News Tags:
Eleven Biotherapeutics
EBI-005
allergic conjunctivitis
Headline:
Eleven Bio faces cash crunch as lead drug flunks another PhIII
Do Not Allow Advertisers to Use My Personal information
